Garron Labs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -13.30%
- Profit Growth 88.73%
- Ebitda 129.07%
- Net Worth -2.67%
- Total Assets 1.53%
About Garron Labs
Garron Labs Private Limited (GLPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 May 2013 and has a history of 11 years and eight months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Zanuar, Ashish Gundecha, and Rahul Bhandari serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909PN2013PTC147604
- Company No.
147604
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2013
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Garron Labs Private Limited offer?
Garron Labs Private Limited offers a wide range of products and services, including Herbal Oil, Massage Oil, Herbal Medicinal Oil.
Who are the key members and board of directors at Garron Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Zanuar  | Director | 15-Mar-2017 | Current |
| Ashish Gundecha | Director | 30-May-2013 | Current |
| Rahul Bhandari | Director | 30-May-2013 | Current |
Financial Performance of Garron Labs.
Garron Labs Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.3% decrease. The company also saw a substantial improvement in profitability, with a 88.73% increase in profit. The company's net worth dipped by a decrease of 2.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Garron Labs?
In 2019, Garron Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bayberry Naturus LlpGopal Zanuar is a mutual person
Bayberry Pharmaceuticals Private LimitedGopal Zanuar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Garron Labs?
Unlock and access historical data on people associated with Garron Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Garron Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Garron Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
